Brokerage Reports
Co-Diagnostics, Inc. [CODX]
Reports for Purchase
Showing records 21 - 40 ( 79 total )
Company: Co-Diagnostics, Inc.
Industry: Medical Services
CODX beats 4Q21 Consensus and guidance for EPS - Reiterate Buy rating and $29 PT
Provider: Univest Securities, LLC
Analyst: Research Department
Price: 12.50
Company: Co-Diagnostics, Inc.
Industry: Medical Services
Strong Financial Performance in 4Q21; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Price: 5.00
Company: Co-Diagnostics, Inc.
Industry: Medical Services
Hepatitis B Viral Load Test Approved in India; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Price: 5.00
Company: Co-Diagnostics, Inc.
Industry: Medical Services
Acquisition of All Assets of the Point-of-Care Testing Platform; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Price: 5.00
Company: Co-Diagnostics, Inc.
Industry: Medical Services
ABC RT-PCR Test Approved in India; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Price: 5.00
Company: Co-Diagnostics, Inc.
Industry: Medical Services
COVID-19 Assay Performance Unaffected by the New Variant; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Price: 5.00
Company: Co-Diagnostics, Inc.
Industry: Medical Services
CODX beats 3Q21 Consensus - Advancing POC Diagnostics - Reiterate Buy rating and $29 PT
Provider: Litchfield Hills Research, LLC
Analyst: O'NEILL T
Price: 12.50
Company: Co-Diagnostics, Inc.
Industry: Medical Services
New Sales Record in 3Q21; Reiterate Buy; Modulating PT to $15
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Price: 5.00
Company: Co-Diagnostics, Inc.
Industry: Medical Services
Dengue-Chikungunya Multiplex Test Cleared in India; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Price: 5.00
Company: Co-Diagnostics, Inc.
Industry: Medical Services
Price: 25.00
Company: Co-Diagnostics, Inc.
Industry: Medical Services
Dengue and Chikungunya Tests Cleared in India; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Price: 10.00
Company: Co-Diagnostics, Inc.
Industry: Medical Services
Price: 25.00
Company: Co-Diagnostics, Inc.
Industry: Medical Services
Intellectual Property Portfolio Strengthened; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Price: 10.00
Company: Co-Diagnostics, Inc.
Industry: Medical Services
COVID-19 Direct Saliva Test Obtains CE Mark; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Price: 10.00
Company: Co-Diagnostics, Inc.
Industry: Medical Services
Top- and Bottom-Line 1Q21 Beat; Volume Growth to Drive Sales; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Price: 25.00
Company: Co-Diagnostics, Inc.
Industry: Medical Services
2020 Financial Results Reported; Reiterate Buy; Lowering PT to $16
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Price: 25.00
Company: Co-Diagnostics, Inc.
Industry: Medical Services
Point-of-Care COVID-19 PCR Testing Platform in Development; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Price: 25.00
Company: Co-Diagnostics, Inc.
Industry: Medical Services
Biotech Should Keep the Wind at its Back in 2021; Top Healthcare Picks
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Price: 75.00
Company: Co-Diagnostics, Inc.
Industry: Medical Services
Sequential Revenue Growth in 4Q20; Reiterate Buy; Raising PT to $30
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Price: 25.00
Company: Co-Diagnostics, Inc.
Industry: Medical Services
3Q20 Financial Results Reported; Reiterate Buy; Lowering PT to $29
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Price: 25.00